Fentanyl produces an anti-hyperalgesic effect through the suppression of sodium channels in mice with painful diabetic neuropathy

European Journal of Pharmacology

Volumn 733, Issue 1, 2014, Pages 68-74

  Tanaka, Ken Ichiro ^a,b   Nakanishi, Yuki ^a   Sekino, Shyota ^a   Ikegami, Megumi ^a   Ikeda, Hiroko ^a   Kamei, Junzo ^a  

^a HOSHI UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Fentanyl; Mouse; Opioid receptor; Painful diabetic neuropathy; Voltage gated sodium channel

Indexed keywords

FENTANYL; FENVALERATE; NALOXONE; OPIATE RECEPTOR; VERATRIDINE; VOLTAGE GATED SODIUM CHANNEL; NARCOTIC ANALGESIC AGENT; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; HYPERALGESIA; LATENT PERIOD; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOZOTOCIN-INDUCED DIABETIC NEUROPATHY; TAIL FLICK TEST; ANIMAL; COMPLICATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM;

ANALGESICS, OPIOID; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FENTANYL; HYPERALGESIA; MALE; MICE, INBRED ICR; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; STREPTOZOCIN;

EID: 84898983576     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.03.042     Document Type: Article

References (52)

1. H. Adriaensen, L. Plaghki, C. Mathieu, A. Joffroy, and K. Vissers Critical review of oral drug treatments for diabetic neuropathic pain-clinical outcomes based on efficacy and safety data from placebo-controlled and direct comparative studies Diabetes Metab. Res. Rev. 21 2005 231 240
2. S.C. Ahlgren, and J.D. Levine Mechanical hyperalgesia in streptozotocin-diabetic rats Neuroscience 52 1993 1049 1055
3. S.C. Ahlgren, and J.D. Levine Protein kinase C inhibitors decrease hyperalgesia and C-fiber hyperexcitability in the streptozotocin-diabetic rat J. Neurophysiol. 72 1994 684 692
4. S.C. Ahlgren, J.F. Wang, and J.D. Levine C-fiber mechanical stimulus-response functions are different in inflammatory versus neuropathic hyperalgesia in the rat Neuroscience 76 1997 285 290
5. A.N. Akopian, L. Sivilotti, and J.N. Wood A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons Nature 379 1996 257 262
6. R. Baron, T.R. Tölle, U. Gockel, M. Brosz, and R. Feynhagen A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: differences in demographic data and sensory symptoms Pain 146 2009 34 40
7. A.J. Boulton, F.A. Gries, and J.A. Jervell Guidelines for diagnosis and outpatient management of diabetic peripheral neuropathy Diabet. Med. 15 1998 508 514
8. J.M. Caffrey, D.L. Eng, J.A. Black, S.G. Waxman, and J.D. Kocsis Three types of sodium channels in adult rat dorsal root ganglion neurons Brain Res. 592 1992 283 297
9. N.A. Calcutt, M.C. Jorge, T.L. Yaksh, and S.R. Chaplan Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine Pain 68 1996 293 299
10. S.R. Chen, K.L. Sweigart, J.M. Lakoski, and H.L. Pan Functional μ-opioid receptors are reduced in the spinal cord dorsal horn in rats Anesthesiology 97 2002 1602 1608
11. S.R. Chen, and H.L. Pan Antinociceptive effect of morphine, but not μ opioid receptor number, is attenuated in the spinal cord of diabetic rats Anesthesiology 99 2003 1409 1414
12. K. Coward, C. Plumpton, P. Facer, R. Birch, T. Carlstedt, S. Tate, C. Bountra, and P. Anand Immunolocalization of SNS/PN3 and NaN/SNS2 sodium channels in human pain states Pain 85 2000 41 50
13. A. Dejgard, P. Petersen, and J. Kastrup Mexiletine for treatment of chronic painful diabetic neuropathy Lancet 1 1988 9 11
14. S.D. Dib-Hajj, L. Tyrrell, J.A. Black, and S.G. Waxman NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomy Proc. Natl. Acad. Sci. USA 95 1998 8963 8968
15. P.J. Dyck, P.J.B. Dyck, T.S. Larson, P.C. O'Brien, and J.A. Velosa Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group Diabetes Care 23 2000 510 517
16. A. Fox, C. Eastwood, C. Gentry, D. Manning, and L. Urban Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat Pain 81 1999 307 316
17. G. Haeseler, N. Foadi, J. Ahrens, R. Dengler, H. Hecker, and M. Leuwer Tramadol, fentanyl and sufentanil but not morphine block voltage-operated sodium channels Pain 126 2006 234 244
18. K. Hashimoto, T. Amano, A. Kasakura, G.R. Uhl, I. Sora, N. Sakai, N. Kuzumaki, T. Suzuki, and M. Narita μ-opioid receptor-independent fashion of the suppression of sodium currents by μ-opioid analgesics in thalamic neurons Neurosci. Lett. 453 2009 62 67
19. M. Hirade, H. Yasuda, M. Omatsu-Kanbe, R. Kikkawa, and H. Kitasato Tetrodotoxin-resistant sodium channels of dorsal root ganglion neurons are readily activated in diabetic rats Neuroscience 90 1999 933 939
20. S. Hong, T.J. Morrow, P.E. Paulson, L.L. Isom, and J.W. Wiley Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat J. Biol. Chem. 279 2004 29341 29350
21. S. Hong, and J.W. Wiley Altered expression and function of sodium channels in large DRG neurons and myelinated A-fibers in early diabetic neuropathy in the rat Biochem. Biophys. Res. Commun. 339 2006 652 660 http://www.ncbi.nlm.nih.gov/pubmed/16310161
22. J.L. Hylden, and G.L. Wilcox Intrathecal morphine in mice: a new technique Eur. J. Pharmacol. 67 1980 313 316
23. 2- opioid receptors Neurosci. Lett. 165 1994 141 143
24. J. Kamei, N. Kawashima, and Y. Kasuya Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic mice Brain Res. 576 1992 139 142
25. J. Kamei, Y. Ohhashi, T. Aoki, N. Kawasima, and Y. Kasuya Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ- and κ-opioid agonists Brain Res. 571 1992 199 203
26. J. Kamei, A. Saitoh, and Y. Kasuya Involvement of delta 1-opioid receptors in the antinociceptive effects of mexiletine in mice Neurosci. Lett. 196 1995 169 172
27. J. Kamei, K. Zushida, M. Ohsawa, and H. Nagase The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice Eur. J. Pharmacol. 391 2000 91 96
28. T. Kohno, R.R. Ji, N. Ito, A.J. Allchorne, K. Befort, L.A. Karchewski, and C.J. Woolf Peripheral axonal injury results in reduced μ opioid receptor pre- and post-synaptic action in the spinal cord Pain 117 2005 77 87
29. P.G. Kostyuk, N.S. Veselovsky, and A.Y. Tsyndrenko Ionic currents in the somatic membrane of rat dorsal root ganglion neurons-I. Sodium currents Neuroscience 6 1981 2423 2430
30. M. Laubie, H. Schmitt, J. Canellas, J. Roquebert, and P. Demichel Centrally mediated bradycardia and hypotension induced by narcotic analgesics: dextromoramide and fentanyl Eur. J. Pharmacol. 28 1974 66 75
31. M. Laubie, H. Schmitt, and M. Drouillat Central sites and mechanisms of the hypotensive and bradycardic effects of the narcotic analgesic agent fentanyl Naunyn-Schmiedeberg's Arch. Pharmacol. 296 1975 255 261
32. + channels by the partial μ-opioid receptor agonist buprenorphine Anesthesiology 116 2012 1335 1346
33. M. Malcangio, and D.R. Tomlinson A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats Pain 76 1998 151 157
34. M. Narita, S. Imai, Y. Itou, Y. Yajima, and T. Suzuki Possible involvement of μ1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites Life Sci. 70 2002 2341 2354
35. S.D. Novakovic, E. Tzoumaka, J.G. McGivern, M. Haraguchi, L. Sangameswaran, K.R. Gogas, R.M. Eglen, and J.C. Hunter Distribution of the tetrodotoxin-resistant sodium channel PN3 in rat sensory neurons in normal and neuropathic conditions J. Neurosci. 18 1998 2174 2187
36. + channels Jpn. J. Pharmacol. 88 2002 365 377
37. 5] enkephalin-induced antinociception in diabetic mice Eur. J. Pharmacol. 339 1997 27 31
38. M. Ohsawa, and J. Kamei Possible involvement of spinal protein kinase C in thermal allodynia and hyperalgesia in diabetic mice Eur. J. Pharmacol. 372 1999 221 228
39. M. Ohsawa, S. Miyata, A. Carlsson, and J. Kamei Preventive effect of acetyl-l-carnitine on the thermal hypoalgesia in streptozotocin-induced diabetic mice Eur. J. Pharmacol. 588 2008 213 216
40. M. Ohsawa, H. Mizoguchi, M. Narita, J. Kamei, H. Nagase, and L.F. Tseng Effects of a μ-opioid receptor agonist on G-protein activation in streptozotocin-induced diabetic mice Eur. J. Pharmacol. 401 2000 55 58
41. P. Oskarsson, J.G. Ljunggren, and P.E. Lins Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. Te Mexilitine Study Group Diabetes Care 20 1997 1594 1597
42. M.H. Ossipov, Y. Lopez, M.L. Nichols, D. Bian, and F. Porreca Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury Neurosci. Lett. 199 1995 83 86
43. M.L. Roy, and T. Narahashi Differential properties of tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels in rat dorsal root ganglion neurons J. Neurosci. 12 1992 2104 2111
44. G. Said Diabetic neuropathy: an update J. Neurol. 243 1996 431 440
45. N. Suzuki, M. Hasegawa-Moriyama, Y. Takahashi, Y. Kamikubo, T. Sakurai, and E. Inada Lidocaine attenuates the development of diabetic-induced tactile allodynia by inhibiting microglial activation Anesth. Analg. 113 2011 941 946
46. T. Syzuki, A. Nurrochmad, M. Ozaki, J. Khotib, A. Nakamura, S. Imai, M. Shibasaki, Y. Yajima, and M. Narita Effect of selective GABA(B) receptor agonist baclofen on the m-opioid receptor agonist-induced antinociceptive, emetic and rewarding effects Neuropharmacology 49 2005 1121 1131
47. S. Tate, S. Benn, C. Hick, D. Trezise, V. John, R.J. Mannion, M. Costigan, C. Plumpton, D. Grose, Z. Gladwell, G. Kendall, K. Dale, C. Bountra, and C.J. Woolf Two sodium channels contribute to the TTX-R sodium current in primary sensory neurons Nat. Neurosci. 1 1998 653 655
48. A. Veves, M. Backonja, and R.A. Malik Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options Pain Med. 9 2008 660 674
49. V. Viola, H.H. Newnham, and R.W. Simpson Treatment of intractable painful diabetic neuropathy with intravenous lignocaine J. Diabetes Complicat. 20 2006 34 39
50. S.G. Waxman The molecular pathophysiology of pain: abnormal expression of sodium channel genes and its contributions to hyperexcitability of primary sensory neurons Pain Suppl. 6 1999 S133 S140
51. R.F. Wolff, M.M. Bala, M. Westwood, A.G. Kessels, and J. Kleijnen 5% lidocaine medicated plaster in painful diabetic peripheral neuropathy (DPN): a systematic review Swiss Med. Wkly. 140 2010 297 306
52. J.M. Wright Review of the symptomatic treatment of diabetic neuropathy Pharmacotherapy 14 1994 689 697